Dexcom advanced the launch of Stelo, its over-the-counter product for non-insulin type 2 diabetes, pre-diabetes, and ...

DexCom plans to launch its 15-day G7 sensor in the second half of ... The Growing Market and Innovation in Continuous Glucose Monitoring (CGM) Technology The WHO estimates […] DXCM faces an ...

Lacey Richards, from Tycroes, survived a coma before becoming the first patient in Carmarthenshire to trial a new diabetes treatment ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM ... for one two-week sensor and £300 for four. There are more than 25 million type 2 diabetes patients ...

As of today, the Government of Saskatchewan’s expanded public coverage for continuous glucose monitoring (CGM) systems comes into effect. Dexcom, Inc. (NASDAQ: DXCM), a global leader in real ...

CGM accuracy was acceptable at rest (12%) but declined considerably during exercise (34%). The discrepancy was larger for hand bikers (41%) compared with conventional cyclists (24%), likely because ...